Related Experiment Video
Updated: Jan 13, 2026

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
Published on: June 6, 2025
From Patterns to Projections: A Spatiotemporal Distribution of Drug-Resistant Tuberculosis in Paraná, Brazil
Laiz Mangini Cicchelero1, Gustavo Cezar Wagner Leandro1, Luciano de Andrade1
1Postgraduate Program in Health Sciences, State University of Maringá (UEM), Maringá 87020-900, Brazil.
Drug-resistant tuberculosis incidence in Paraná, Brazil, shows an increasing trend, particularly in the North and Northwest regions. Urgent surveillance is needed to control spread and work towards tuberculosis elimination.
Area of Science:
- Epidemiology
- Public Health
- Infectious Disease Dynamics
Background:
- Drug-resistant tuberculosis (DR-TB) poses a significant global health threat due to its high transmissibility.
- Understanding the epidemiological patterns of DR-TB is crucial for effective control strategies.
Purpose of the Study:
- To analyze the prevalence, incidence, and spatiotemporal patterns of drug-resistant tuberculosis in Paraná, Brazil, from 2012 to 2023.
- To forecast future trends of DR-TB incidence through 2030.
Main Methods:
- Ecological study utilizing national surveillance data.
- Employed descriptive statistics, Mann-Kendall trend tests, spatial analysis (Moran's I, spatial scan statistic), and time series forecasting (SARIMA).
Main Results:
- Identified 576 DR-TB cases with an overall incidence of 5.08 per 100,000, showing a significant increasing trend (p < 0.001).
- Isoniazid monoresistance was the most common resistance profile. Higher prevalence observed in males, young adults (15-34 years), and among Asian and Black populations.
- Spatial analysis revealed expansion over time, with persistent high-risk clusters identified in the North and Northwest regions.
Conclusions:
- The study indicates a concerning rise in drug-resistant tuberculosis incidence in Paraná, with specific regional hotspots.
- Forecasting suggests a continued increase through 2030 if current trends persist.
- Enhanced surveillance, treatment adherence monitoring, and transmission interruption are vital for achieving tuberculosis elimination goals.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Development of Antibiotic Resistance